A randomized, double-blind, two arm, parallel group health assessment study of losartan or atenolol in patients with mild to moderate hypertension
Latest Information Update: 05 May 2022
Price :
$35 *
At a glance
- Drugs Losartan (Primary) ; Atenolol
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors Organon
- 19 Oct 2007 New trial record.